Market revenue in 2024 | USD 57.9 million |
Market revenue in 2030 | USD 138.0 million |
Growth rate | 15.6% (CAGR from 2024 to 2030) |
Largest segment | Adult stem cells |
Fastest growing segment | Induced Pluripotent Stem Cells |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.94% in 2024. Horizon Databook has segmented the UAE stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE stem cells market is growing at a rapid rate on account of considerable support received from the local government and the healthcare transformation mission undertaken for the next few years. With rapid expansion of cell banks and increase in awareness about stem cell preservation, the market for stem cells is expected to reach new highs in coming years.
Medical tourism in the UAE is one of the key healthcare subsets gaining popularity. As a result of this, the Dubai Health Authority announced setting up new nationwide stem cells banks. With this, a national registry will be setup for improvement of current research landscape and regulatory aspects.
Improvement in medical access to people is also one of the key factors for the market growth in the UAE. In February 2020, frozen stem cells were used for treating blood cancer during a bone marrow transplant. This was the first time when cryogenically preserved stem cells were used.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE stem cells market , including forecasts for subscribers. This country databook contains high-level insights into UAE stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account